Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Apr 26;55(8):3878-90.
doi: 10.1021/jm3001086. Epub 2012 Apr 4.

Synthesis, Binding Affinity, and Functional in Vitro Activity of 3-benzylaminomorphinan and 3-benzylaminomorphine Ligands at Opioid Receptors

Affiliations
Free PMC article

Synthesis, Binding Affinity, and Functional in Vitro Activity of 3-benzylaminomorphinan and 3-benzylaminomorphine Ligands at Opioid Receptors

John L Neumeyer et al. J Med Chem. .
Free PMC article

Abstract

A series of 3-benzylamino-3-desoxymorphinan (I) and 3-benzylamino-3-desoxymorphine (II) derivatives were synthesized and evaluated for their binding affinities, and functional activity data are presented at MOR, KOR, and DOR. Some of these ligands were found to have high binding affinity at MOR and KOR and displayed increased selectivity at MOR over KOR and DOR compared to butorphan or cyclorphan. The most selective compound, 3-(3'-hydroxybenzyl)amino-17-methylmorphinan (4g) (24-fold MOR to KOR and 1700-fold MOR to DOR) also showed high binding affinity (0.42 nM to MOR) and was a full agonist in the [(35)S]GTPγS binding assay. 2-(3'-Hydroxybenzyl)amino-17-cyclopropylmethylmorphinan (17) was found to be a KOR-selective ligand (150-fold over MOR and >10000-fold over the DORs). Most 3-benzylaminomorphinan derivatives were partial agonists at MOR and full agonists at KOR in the [(35)S]GTPγS binding assay.

Figures

Scheme 1
Scheme 1
Synthesis of 3-benzylamino-morphinan analogues
Scheme 2
Scheme 2
Synthesis of 3-benzylamino-3-morphine analogues
Scheme 3
Scheme 3
Synthesis of 2-(3′-hydroxybenzyl)amino-3-cyclorphan

Similar articles

See all similar articles

Cited by 1 article

Publication types

LinkOut - more resources

Feedback